Photo of Faina Nakhlis,   M.D.

Faina Nakhlis, M.D.

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 983-7777


fnakhlis@partners.org

Faina Nakhlis, M.D.

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Assistant Professor, Surgery, Harvard Medical School

DF/HCC PROGRAM AFFILIATION

Research Abstract

My research interests include the natural history and surgical management of premalignant breast lesions, inflammatory breast cancer (IBC), local therapy for metastatic locally advanced breast cancer, the mechanisms of tumor resistance.

Publications

Powered by Harvard Catalyst
  • Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR. Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management. Ann Surg Oncol 2015. PubMed
  • Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR. Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. Breast Cancer Res Treat 2015; 151:225-32. PubMed
  • Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol 2015; 22:1479-82. PubMed
  • Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 2006; 12:428-30. PubMed
  • Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, Giess CS, Hirshfield-Bartek J, Overmoyer B, Van den Abbeele AD. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach. Radiographics 2013; 33:2003-17. PubMed